Otonomy Reports First Quarter 2021 Financial Results and Provides Corporate Update

Back to Jobs

OTO -313 Phase 2 trial in tinnitus initiated with results expected in mid-2022 OTO -413 Phase 1/2 trial expansion in hearing loss expected to start in second quarter of 2021 with results anticipated in mid-2022 OTO -825 IND-enabling activities underway with preclinical proof-of-concept data to be

Apply Now